Moderna Q2: Focus On The Light At The End Of The Tunnel
Moderna(MRNA) Seeking Alpha·2024-08-02 20:30
hapabapa Moderna: Endured A 20% Fall Yesterday Moderna, Inc. (NASDAQ:MRNA) investors endured a torrid earnings release that added more pressure on MRNA, as the stock has declined almost 45% from its May 2024 highs. As a result, there's no doubt that it has plunged firmly into a bear market as the market reassessed its optimism about the embattled MRNA Covid vaccine maker. While the world wants to move on from Covid, it should be noted that the dreaded disease isn't expected to disappear. The World Health Or ...